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Abstract
AIM
To determine if manipulation of dietary advanced 
glycation end product (AGE), intake affects non-
alcoholic fatty liver disease (NAFLD) progression and 
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whether these effects are mediated via  RAGE. 
METHODS
Male C57Bl6 mice were fed a high fat, high fructose, 
high cholesterol (HFHC) diet for 33 wk and compared 
with animals on normal chow. A third group were 
given a HFHC diet that was high in AGEs. Another 
group was given a HFHC diet that was marinated in 
vinegar to prevent the formation of AGEs. In a second 
experiment, RAGE KO animals were fed a HFHC diet 
or a high AGE HFHC diet and compared with wildtype 
controls. Hepatic biochemistry, histology, picrosirius red 
morphometry and hepatic mRNA were determined. 
RESULTS
Long-term consumption of the HFHC diet generated 
significant steatohepatitis and fibrosis after 33 wk. In 
this model, hepatic 4-hydroxynonenal content (a marker 
of chronic oxidative stress), hepatocyte ballooning, 
picrosirius red staining, α-smooth muscle actin and 
collagen type 1A gene expression were all significantly 
increased. Increasing the AGE content of the HFHC 
diet by baking further increased these markers of liver 
damage, but this was abrogated by pre-marination 
in acetic acid. In response to the HFHC diet, RAGE-/- 
animals developed NASH of similar severity to RAGE+/+ 
animals but were protected from the additional harmful 
effects of the high AGE containing diet. Studies in 
isolated Kupffer cells showed that AGEs increase cell 
proliferation and oxidative stress, providing a likely 
mechanism through which these compounds contribute 
to liver injury. 
CONCLUSION
In the HFHC model of NAFLD, manipulation of dietary 
AGEs modulates liver injury, inflammation, and liver 
fibrosis via  a RAGE dependent pathway. This suggests 
that pharmacological and dietary strategies targeting 
the AGE/RAGE pathway could slow the progression of 
NAFLD. 
Key words: Advanced glycation end-products; Fructose; 
Steatohepatitis; Non-alcoholic fatty liver disease; 
Hepatic fibrosis; Oxidative stress
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Core tip: A novel high fructose, high cholesterol diet 
produces hepatic non-alcoholic steatohepatitis (NASH) 
with fibrosis in 33 wk and increasing the Advanced 
glycation end products (AGEs), content of this diet 
via  baking increases hepatic fibrosis whilst vinegar 
marination decreases dietary AGE levels, abrogating 
the harmful effects of AGEs. RAGE-/- animals appeared 
to be protected from the additional harmful effects 
of a high AGE containing diet suggesting the central 
role of RAGE in progression of NASH. Increased cell 
proliferation and oxidative stress in isolated primary 
Kupffer cells with the addition of AGEs suggests they 
are an important mechanism in which AGEs contribute 
to liver injury.
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INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) is the 
most common liver disease in the world and is 
strongly linked to the burgeoning rates of diabetes 
and obesity[1]. Although most patients with NAFLD 
are asymptomatic and do not develop clinically 
significant liver injury, many progress to non-alcoholic 
steatohepatitis (NASH), cirrhosis and liver cancer. 
However, the host and/or environmental risk factors 
that determine whether patients with simple hepatic 
steatosis go on to develop NASH and its complications 
remain unclear[2].
Advanced glycation end products (AGEs), also 
known as glycotoxins, are a complex group of com-
pounds that are formed when active sugar moieties 
become bound to proteins causing browning and other 
irreversible modifications[3]. Foods that are highly pro-
cessed or dry heated at high temperatures, such as 
broiled foods, have particularly high AGE content[4]. 
However, they are also formed endogenously and this 
occurs at an increased rate in diabetes, most likely 
because of hyperglycaemia. There is now considerable 
evidence that accumulation of AGEs are implicated in 
the pathogenesis of diabetic renal, neurological, retinal 
and vascular complications[5]. 
AGEs act on several receptors but the receptor 
for advanced glycation end products (RAGE), a 
member of the immunoglobulin superfamily of cell-
surface molecules, is the best characterised of these 
receptors[6]. Engagement with RAGE, which in turn 
increases inflammation and oxidative stress is thought 
to be the main way in which AGEs impart these 
pathogenic effects[7]. This receptor is expressed in a 
number of cell types, including endothelial cells, vascular 
smooth muscle cells, peripheral blood mononuclear 
cells, macrophages (including Kupffer cells) and HSCs[8]. 
A number of lines of evidence to suggest that, in 
NAFLD, AGEs may be a “second hit” that contributes 
to the progression from simple steatosis to NASH and 
liver fibrosis[9]. Several studies have shown that RAGE 
plays a role in acute liver injury and that blockade of 
RAGE can ameliorate toxic, ischaemic and cholestatic 
liver damage[10-12]. In chronic liver injury, hepatic 
expression of RAGE is significantly increased[13], 
and in NAFLD AGE levels correlate with the severity 
of fibrosis, leading to speculation that AGEs play a 
primary role in disease pathogenesis[14]. At a cellular 
level, AGEs induces ROS via oxidative stress[15] and this 
is a significant mechanism underlying the pathogenesis 
of NASH[16]. Furthermore, diabetes, which increases 
AGE formation RAGE expression and oxidative stress, 
worsens the progression of fibrosis in a number of 
human liver diseases, including NAFLD[17] and hepatitis 
C[18]. 
In a previous study, we showed that in a short 
term methionine choline deficient (MCD) model 
of NAFLD, a high AGE diet increased hepatic AGE 
content and exacerbated liver injury, oxidative stress 
and liver fibrosis and that AGEs produced RAGE 
dependent profibrotic effects in activated hepatic 
stellate cells (HSCs)[19]. However, the relevance of 
the MCD model to human disease is limited since 
the metabolic profile of MCD fed animals is generally 
the converse of human NAFLD[20]. In contrast, long-
term murine models based on a high-calorie diet high 
in fat, fructose and cholesterol [high fructose, high 
cholesterol (HFHC) diet], yield NASH associated with 
many of the metabolic features of human NASH[21]. 
The aim of the current study was to explore whether 
increasing dietary AGE consumption could precipitate 
the development of NASH in a novel HFHC model of 
NAFLD. We also performed complementary studies 
in RAGE KO animals to determine the role of RAGE 
signalling in our liver disease model. 
MATERIALS AND METHODS
Experimental design
Experiments were approved by the Austin Health 
Animal Ethics Committee and performed according 
to the National Health and Medical Research Council 
(NHMRC) of Australia Guidelines for animal experi-
mentation.
Male C57Bl6 mice (n = 10/group) were fed a 
high fat, high fructose, high cholesterol (HFHC) diet 
[Specialty Feeds SF11-109 (21% saturated fat, 10% 
fructose, 2% cholesterol)] for 33 wk and compared 
with animals on normal chow (Specialty Feeds 
AIN93G). This is a novel dietary model combining 
amounts of saturated fat (especially animal fats such 
as ghee) and fructose to mimic unhealthy Western 
diets[22]. This model is different to other high fat diets 
in that we gave amounts of fat actually consumed 
by patients for a longer period to induce fibrosis[23]. 
Two percent cholesterol was incorporated as this has 
been shown to be a critical driver for fibrosis in mu-
rine dietary models of NASH[22] and 10% fructose was 
added, both due to its prevalence in Western diet as 
well as its potent ability to induce AGE formation[24] 
(See Supplementary materials 2). In two further 
groups, the effects of further increasing dietary AGE 
content by baking (described below), were studied 
in animals fed normal chow and in animals fed the 
HFHC diet. A final group was fed a baked HFHC diet 
that was marinated in acetic acid (vinegar 4% w/v) 
prior to heating to prevent the formation of AGEs, as 
is seen in Mediterranean style diets[25]. In a second 
experiment, RAGE KO animals were fed a HFHC diet 
or a high AGE HFHC diet for 33 wk and compared with 
WT controls. At the completion of each experiment, 
insulin resistance was measured via HOMA-IR and 
oral glucose tolerance testing (OGTT) performed as 
previously described[26]. Livers were harvested for 
assessment of liver injury and serum alanine amino-
transaminase (ALT) levels were measured by auto-
analyser (Beckman Instruments, Fullerton, CA).
Production of AGEs
Dietary AGE content was increased by baking at 160 ℃ 
for 1 h which we have previously shown produces 
an approximately 4 fold increase in AGE levels[12]. 
CML is the predominant AGE in food and the extent 
of advanced glycation in the diet was assessed by 
measuring CML content using high performance liquid 
chromatography with fluorescence detection against 
authentic standards of CML[27]. 
For cell studies, AGEs were prepared in vitro by 
incubating bovine serum albumin (BSA, 50 mg/mL) with 
0.5 mol/L glucose in 100 mmol/L sodium phosphate 
buffer, pH 7.4. This was incubated at 37 ℃ for 6 wk, 
followed by dialysis against phosphate buffered saline 
(PBS) for 48 h at 4 ℃ to remove any free glucose. 
AGE-BSA and BSA were then passed through an 
endotoxin column (Detoxigel, Pierce, Rockford, IL, 
United States) to remove any possible endotoxin 
contaminants. The extent of advanced glycation was 
assessed by CML levels with ELISA and by isotope 
dilution, selected ion monitoring gas chromatography-
mass spectrometry[12,27]. 
Liver histology
Paraffin embedded, paraformaldehyde fixed sections of 
liver (4 µm) were stained with haematoxylin and eosin 
and picrosirius red (Polysciences Inc. Warrington, PA) 
for assessment of liver fibrosis and steatohepatitis by 
an independent pathologist. The NAFLD Activity Score 
(NAS) system was used to quantify steatohepatitis 
using ten × 200 light microscopic fields in a blinded 
fashion as previously described[28]. Each field was 
scored using the following criteria: For hepatic 
steatosis: grade 0, no fat; grade 1, steatosis occupying 
less than 33% of the hepatic parenchyma; grade 
2, 34%-66% of the hepatic parenchyma; grade 
3, more than 66% of the hepatic parenchyma; for 
inflammatory cell infiltration: grade 0:none; grade 1, 
1-2 foci/field; grade 2, 3-4 foci/field; grade 3, more 
than 4 foci/field (steatosis 0-3, lobular inflammation 
0-2, hepatocellular ballooning 0-3 and fibrosis 0-4)[28]. 
Collagen content of the liver was quantified histolo-
gically using computerized quantification of picrosirius 
red staining, as described previously[12]. This was 
assessed at × 100 magnification in a total of ten 
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Kupffer cell experiments
Kupffer cells (KCs) were isolated from rat livers as 
described previously[30,31]. Further details can be found 
in Supplementary materials 1. KCs were cultured in 
M199 medium (Invitrogen), supplemented with 10% 
(v/v) FCS (foetal calf serum) containing 100 units/mL 
penicillin and 100 µg/mL streptomycin (Invitrogen), at 
37 ℃ in an oxygenated, humidified cabinet containing 
5% CO2. 
Twenty thousand KCs per well were plated in black 
96 well plates at 37 ℃. The cells were incubated with 
2′,7′-dichlorodihydrofluorescein diacetate (DCFDA) 
(10 µmol/L, Sigma-Aldrich, St Louis, MO, United 
States) for 30 min, and washed twice with PBS. The 
cells were then treated with either AGEs or vehicle 
BSA at physiological concentrations of 100 µg/mL. 
Measurement of intracellular ROS generation was 
performed using 2′,7′-dichlorodihydrofluorescein 
diacetate (DCFDA) as described previously[32]. Briefly, 
fluorescence measurements were taken with excitation 
and emission wavelengths of 485 nm and 520 nm 
respectively on an Optima Microplate Reader (BMG 
Labtech, Mornington, Australia).
KCs were assayed for their proliferative response 
to AGEs using a BrdU cell proliferation assay (Roche 
Applied Science, IN, United States) as per manu-
facturer’s instructions. KCs were cultured in 96 well 
plates, with 10000 cells per well and treated with BSA 
and AGEs at 100 µg/mL. 
Statistical analysis
Results are expressed as mean ± SE and analysed 
by analysis of variance (ANOVA) and Student’s two-
tail, unpaired t-test where appropriate with Prism 
5 software (GraphPad Software, San Diego, United 
States). Data that were not normally distributed with 
equal variance were log transformed prior to analysis. 
P < 0.05 was considered significant. 
RESULTS
Novel 33 week high fat, HFHC dietary model of NAFLD 
produced both steatohepatitis and significant fibrosis
The HFHC diet was well tolerated and the initial body 
weights of the experimental groups were similar. 
All the HFHC groups (HFHC, HFHC baked and HFHC 
baked + acetic acid) gained more weight, as expected, 
over the 33 wk compared with normal chow mice, 
and there was no final difference in weight gain, liver 
weight or liver to body weight ratio among the HFHC 
groups (Table 2). The daily weight of chow consumed 
each day was the same in all the HFHC groups
The diet produced features similar to human NASH 
with ballooning of hepatocytes and oxidative stress as 
assessed by HNE accumulation and steatosis grade > 
3 (Figure 1A-C), with significant increases in ALT and 
lobular inflammation (Figure 1D and E). The diet also 
induced hepatic fibrosis with the typical “river delta” 
tendrils of lobular fibrosis seen in fibrotic human NASH 
fields per section (per animal), using computerized 
quantification and results were expressed as proportion 
of picrosirius red staining per field. 
Assessment of hepatic oxidative stress
Superoxide anion and ROS are key mediators of 
liver injury and cellular dysfunction associated with 
the progression of fatty liver disease. Immuno-
histochemistry for HNE, a marker of lipid peroxidation, 
was performed on 4 µm sections of paraffin embedded 
liver as previously described[12]. The primary HNE 
antibody (1:500 Alpha Diagnostic International, San 
Antonio, Texas, United States) in 0.1% normal goat 
serum with PBS was applied and then incubated with 
biotinylated secondary goat anti-mouse antibody 
(1/100) followed by incubation with avidin-biotin 
horseradish peroxidase. Peroxidase conjugates 
were subsequently localized using diaminobenzidine 
tetrahydrochloride chromogen (Sigma-Aldrich, Sydney, 
Australia). The relative positive staining in each group 
was determined by computerized quantification 
(MCID; Imaging Research, Ontario, Canada) at × 100 
magnification (10 fields per animal). 
Quantitative real time PCR
Total RNA was extracted using TRI reagent (Sigma-
Aldrich) and reverse transcribed to cDNA using a 
protocol previously described[29]. Gene expression 
was normalized to the expression of the endogenous 
control, ribosomal 18S. Each sample was run and 
analysed in duplicate. The normalized values from 
normal chow livers were used as the calibrator with a 
given value of 1 and the other groups compared with 
this calibrator. The gene probe, forward and reverse 
primer sequences are detailed in Table 1.
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Table 1  Primer and probe sequences used for real time qPCR
Gene name Probe/
primer 
Sequence
IL-6 Probe 5-FAM ATTGCCATTGCACAACT-3
Forward 5-GGGAAATCGTGGAAATGAGAAA-3
Reverse 5-AAGTGCATCATCGTTGTTCATACA-3
MCP1 Probe 5-FAM-AATGGGTCCAGACATAC-3
Forward 5-GTCTGTGCTGACCCCAAGAAG-3
Reverse 5-TGGTTCCGATCCAGGTTTTTA-3
TNFα Probe 5-FAM-TCACCCACACCGTCAG-3
Forward 5-GGCTGCCCCGACTACGT-3
Reverse 5-TTTCTCCTGGTATGAGATAGCAAATC-3
RAGE Probe 5-FAM-CACAGCCCGGATTG-3
Forward 5-GCTGTAGCTGGTGGTCAGAACA-3
Reverse 5-CCCCTTACAGCTTAGCACAAGTG-3
alphaSMA Probe 5-FAM-TGCCAGATCTTTTCC-3
Forward 5-GACGCTGAAGTATCCGATAGAACA-3
Reverse 5-GGCCACACGAAGCTCGTTAT-3
COL1A1 Probe 5-FAM-ATCGACCCTAACCAAG-3
Forward 5-GACTGGAAGAGCGGAGAGTACTG-3
Reverse 5-CCTTGATGGCGTCCAGGTT-3
CTGF Probe 5-FAM-C ACTGCCTGGTCCAGAC-3
Forward 5-GCTGCCTACCGACTGGAAGA-3
Reverse 5-CTTAGAACAGGCGCTCCACTCT-3
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(Figure 2A). This was associated with an elevation in 
profibrotic and proinflammatory cytokine expression 
in the liver (Figure 2B and C, Supplementary materials 
3). Thus using a combination of physiological amounts 
of fat, fructose and a prolonged duration of feeding, a 
reliable model of NASH with fibrosis was generated. 
Importantly this diet did not result in insulin resistance 
in any of the groups as measured by blood glucose 
OGTT (Table 2).
Diet high in AGEs did not cause steatosis or 
steatohepatitis in the normal liver (normal chow 
animals)
Both normal chow and normal chow baked groups 
had similar food intake and there was no difference 
in weight gain, liver weight or liver to body weight 
ratio between the two groups. In line with previous 
studies[19], baking the normal chow diet increased 
AGE content by over 6 fold (Figure 3) but feeding with 
baked chow did not change liver biochemistry, produce 
steatosis, oxidative stress or fibrosis (Figures 1 and 2). 
Changes in dietary AGE content modulate oxidative 
stress and hepatocyte ballooning in HFHC induced 
steatohepatitis
Baking the HFHC diet markedly increased CML content 
(Figure 3). Other studies have shown that pre-
marination of food in vinegar decreases AGE levels to 
much lower levels comparable to raw food or boiled 
food. Importantly, the pre-marination of the HFHC baked 
diet with acetic acid reduced CML levels in the baked diet 
to non-baked levels (Figure 3). These AGE levels in the 
HFHC baked diet are similar to the CML levels found in a 
moderate to high AGE typical Western diet[33].
Steatosis was significantly increased in all HFHC 
groups but not further increased by baking to 
increase its AGE content (Figure 1C). However, the 
ballooning produced by HFHC feeding was further 
increased by the high AGE/HFHC diet and this effect 
was inhibited by the reduction in dietary AGE content 
achieved by vinegar pre-marination (Figure 1A). 
Oxidative stress is strongly implicated in liver injury 
and ballooning degeneration in NASH. Higher levels 
of HNE were detected in the livers of the HFHC high 
AGE group compared to those fed the HFHC diet 
alone. Furthermore, hepatic HNE content was reduced 
to the levels observed in the HFHC group when AGE 
content of the diet was reduced by acetic acid (Figure 
1B). These findings implicate increased generation of 
oxidative stress in the pathogenesis of AGE mediated 
injury in this model.
We previously showed that AGEs increase activation 
and proliferation of hepatic stellate cells and lead to the 
production of ROS by these cells[19]. However KCs are 
responsible for hepatic AGE uptake and play a central 
role in NASH pathogenesis. We therefore isolated 
primary KCs to determine the effects of AGEs on these 
key drivers of inflammation and injury in NAFLD. 
As shown in Figure 4A, the generation of ROS by 
isolated Kupffer cells, as measured by 2,3-DCFDA, was 
significantly increased by the addition of AGEs to the 
medium compared to vehicle. Moreover, Kupffer cell 
proliferation as assessed by BrDU incorporation was 
also significantly increased in Kupffer cells exposed to 
AGEs compared to BSA vehicle alone (Figure 4B).
Lobular inflammation, ALT levels and proinflam-
matory cytokine expression were all significantly 
increased in the HFHC model (Figure 1D and E, 
supplement 3) but were not affected by the dietary 
AGE content.
Modulation of dietary AGE content increased markers of 
liver fibrosis in the HFHC model
As outlined above, in this novel HFHC model, fibrosis 
was largely confined to zone 3 and produced a sinu-
soidal pericellular fine “river delta” pattern. This is in 
keeping with human NASH where fibrosis tends to 
follow a centrizonal pattern[34]. The proportional area 
stained was further increased when the HFHC diet had 
been baked to increase AGE content (Figure 2A). In 
addition to more pronounced zone 3 fibrosis, periportal 
fibrosis was also observed in HFHC high AGE fed 
animals following the pattern of fibrosis progression 
in human NAFLD[34]. However, the portal pattern of 
inflammation was not affected by changing dietary 
AGE content.
In keeping with the results of picrosirius red 
staining, COL1A gene expression was significantly 
increased in both HFHC groups compared with normal 
chow controls and levels were higher in the mice 
with a high oral intake of AGEs compared with HFHC 
alone (Figure 2B). Activation of myofibroblasts, as 
assessed by hepatic α-SMA gene expression was also 
significantly increased in the HFHC model and further 
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Table 2  Animal characteristics and metabolic findings
Body weight (g) Epididymal fat (g) Liver weight (g) Blood glucose (mmol/L) OGTT (AUC)
Normal chow  35.4 ± 1.5a  1.4 ± 0.2a  1.3 ± 0.1a 8.0 ± 0.7 654.1 ± 94.4
HFHC 43.4 ± 1.7 2.7 ± 0.2 3.7 ± 0.4 8.2 ± 0.6 528.7 ± 65.2
HFHC baked 45.5 ± 1.2 2.8 ± 0.2 3.4 ± 0.5 7.8 ± 0.3 506.2 ± 70.2 
HFHC baked and acetic acid 44.6 ± 0.9 2.6 ± 0.1 3.6 ± 0.2
Data are mean ± SEM at 33 wk of normal chow or high fat high cholesterol feeding. aP < 0.01 vs HFHC groups. AUC: Area under the curve; OGTT: Oral 
glucose tolerance test.
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Figure 1  Novel 33 wk high fructose, high cholesterol dietary model induced changes of non-alcoholic steatohepatitis. A: Haematoxylin and eosin 
stained sections showing ballooning after high fructose, high cholesterol (HFHC) diets (examples of ballooning circled). At right, ballooning scores determined 
morphometrically; B: Oxidative stress revealed by the immunohistochemical localisation of 4-hydroxynonenal; C: Steatosis grade (grade 0, no fat; grade 1, steatosis 
occupying less than 33% of the hepatic parenchyma; grade 2, 34%-66% of the hepatic parenchyma; grade 3, more than 66% of the hepatic parenchyma); D: Plasma 
levels of alanine transaminase (ALT) in the different treatment groups; and E: Lobular inflammation (grade 0:none; grade 1, 1-2 foci/field; grade 2, 3-4 foci/field; grade 
3, more than 4 foci/field). Ballooning and oxidative stress were significantly increased by raising the AGE content of the HFHC diet. These changes were attenuated 
when dietary AGE content was reduced by acetic acid premarination. aP < 0.05, bP < 0.01, cP < 0.001. 
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increased (P < 0.05) with high oral intake of AGEs 
(Figure 2C). 
The role of AGEs in mediating increased liver 
fibrosis was further supported by the finding that 
picrosirius staining, COL 1A gene expression and 
hepatic α-SMA gene expression were reduced to those 
observed in animals fed the HFHC diet alone, with 
vinegar pre-marination to reduce AGE content during 
baking (Figure 2B and C).
Pathological effects of dietary AGEs are RAGE 
dependent
In diabetes, many of the harmful effects of AGEs are 
thought to be mediated via AGE/RAGE signalling[35]. 
RAGE expression, as measured by immunohistoche-
mistry[19], was minimal in healthy liver from animals 
fed normal chow however RAGE expression was 
increased in all HFHC groups compared to animals fed 
standard chow (Figure 2D).
Given the putative role of RAGE in mediating the 
8034 September 21, 2016|Volume 22|Issue 35|WJG|www.wjgnet.com
Figure 2  Elevation in profibrotic and proinflammatory cytokine expression in the liver. A: Picrosirius red staining of collagen showing centrilobular sinusoidal 
fibrosis induced by the 33 wk high fructose, high cholesterol (HFHC) dietary model (c). In animals receiving the HFHC diet, fibrosis was further increased by raising 
the advanced glycation end products (AGEs) content of the diet (d) and attenuated when dietary AGE content was reduced by acetic acid premarination prior to 
baking (e). However increasing the AGE content of normal chow did not cause increased fibrosis (compare a, b). Hepatic gene expression of COL1A (B) and αSMA (C) 
were also significantly increased by raising the AGE content of the diet. Expression of RAGE, a key receptor for AGEs, was elevated in the HFHC model but this was 
not affected by varying the AGE content of the diet, aP < 0.05, bP < 0.01 (D). 
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Figure 3  Levels of carboxymethyl lysine in the different diets. Baking 
the high fructose, high cholesterol (HFHC) diet and normal chow increased 
CML content of feed by > 6 fold. Levels of CML were markedly reduced by 
premarinating with vinegar prior to baking, bP < 0.01. 
Figure 4  Effects of advanced glycation end products on reactive 
oxygen species and proliferation in isolated Kupffer cells exposed to 
physiological amounts of dietary advanced glycation end products 
compared with bovine serum albumin vehicle. A: Advanced glycation 
end products (AGEs) increased ROS generat ion as measured by 
2’,7’-dichlorodihydrofluorescein diacetate. B: AGEs increased cell proliferation 
as assessed by BrDU incorporation, aP ≤ 0.05. 
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harmful effects of AGEs and the finding that its expres-
sion was increased in our dietary model, we performed 
a further study in which we examined whether RAGE 
deletion abrogated liver injury and the harmful effect 
of AGEs in the HFHC model. As in the initial study, 
in this experiment, HFHC diet induced liver fibrosis 
and 4HNE staining were increased by raising dietary 
AGE content and the area of fibrosis was expanded to 
include the periportal region (Figure 5A-C). 
RAGE KO animals fed the HFHC diet had similar 
levels of fibrosis to wild type animals (5A). However 
RAGE KO animals appeared to be protected from the 
increased liver fibrosis induced by AGEs. Compared 
to wild type animals fed the high AGE/HFHC diet, 
there was less picrosirius staining and COL 1A gene 
expression in the RAGE deleted animals (Figure 
5A-B). The increased oxidative stress in animals fed 
a HFHC baked diet was also abrogated significantly in 
corresponding RAGE KO animals (Figure 5C). However, 
HNE levels did not return back to normal chow levels. 
These findings suggest that AGEs act via RAGE to 
increase liver fibrosis in this model of experimental 
NASH.
DISCUSSION
Our experiments show that AGEs may be important 
modifiable dietary cofactors which contribute to the 
development of liver fibrosis in NAFLD. The current 
findings are in keeping with previous studies which 
showed that AGEs administered intraperitoneally or 
in the diet exacerbate liver injury and fibrosis[12,19]. 
However these previous experiments were conducted 
in short term models of liver disease of limited 
relevance to human NAFLD[36]. For the present studies, 
therefore, a novel model of NAFLD was developed using 
physiological amounts of fat, cholesterol and fructose 
that occur in human diets and it reliably produced 
slowly progressive steatosis, ballooning, oxidative stress 
and predominantly pericentral sinusoidal fibrosis with a 
tempo of disease consistent with the long progressive 
natural history of human NASH. In this study, all of 
these key features of high fat diet induced NASH were 
exacerbated by increasing dietary AGE content
The two-hit hypothesis of NASH pathogenesis 
suggests that a second injury or cofactor is required for 
progression from simple benign steatosis to harmful 
steatohepatitis or fibrosis, cirrhosis and hepatocellular 
carcinoma[37]. There has been considerable interest in 
factors which could serve as this “second hit”. In line 
with our previous study in MCD animals[19], we found 
that a high AGE containing diet has no effect on liver 
biochemistry or histology in animals without hepatic 
steatosis. However, we showed they act as a co-factor 
to increase injury in diseased livers.
AGEs have been shown to exert their effects 
through several receptors, the best studied of which 
is RAGE. Activation of RAGE stimulates multiple signal 
transduction pathways[38], ultimately leading to the 
generation of ROS[39]. This culminates in the activation 
of NF-κB, a redox sensitive transcription factor, which 
in turn translocates into the nucleus[40]. The promoter 
region of the RAGE gene contains an NF-κB binding 
site and therefore, one of the important consequences 
of NF-κB activation and translocation is upregulation of 
RAGE itself. This sets up a positive feedback loop and 
ensures maintenance of RAGE signalling. Furthermore, 
the generation of ROS triggered by RAGE activation 
causes increased AGE formation and contributes to a 
vicious cycle of AGE formation, generation of oxidative 
stress and further RAGE activation[7]. Our study 
showed that RAGE expression was minimal in healthy 
livers but upregulated in a non-diabetic model of fatty 
liver disease. These differences in RAGE expression 
may explain why the high AGE diet had no harmful 
effects in healthy controls but exacerbated liver injury 
in animals with NAFLD. However, since the dietary 
AGE content of normal mouse chow is so high it is also 
feasible that the dietary AGE content of normal mouse 
chow is so high that mice become preconditioned 
against the effects of further increases. In keeping 
with these findings, although RAGE KO animals 
developed NASH in response to the HFHC diet they 
were protected from the additional harmful effects of 
the high AGE diet. 
Oxidative stress and the accumulation of superoxide 
is a key mediator of ballooning, cellular dysfunction 
and fibrosis in non-alcoholic steatohepatitis[7,41]. HNE, 
an end-product of peroxidation of membrane N-6-
polyunsaturated fatty acids, is a particularly good 
marker of lipid oxidation during liver injury and is 
related to the intensity of necroinflammation[42]. Given 
the long- term nature of our model, assessment of 
oxidative stress in the liver was therefore performed 
by measuring HNE adducts which reflect accumulation 
of oxidative stress over time. This showed that HNE 
content was significantly elevated in all the HFHC 
groups (Figure 1C). Consistent with the known effects 
of AGEs, we found that a diet high in AGEs significantly 
increased oxidative stress in HFHC induced NASH. 
This was associated with increased ballooning, stellate 
cell activation as assessed by aSMA expression and 
increased fibrosis. These findings are consistent with 
our previous work which showed that in activated 
primary murine hepatic stellate cells which express 
RAGE, ROS production, cell activation and proliferation 
were markedly increased in the presence of AGEs. 
These effects were inhibited by RAGE blockade or 
NADPH oxidase inhibition. However, Kupffer cells (KCS) 
express RAGE[43] and uptake of AGEs in the liver occurs 
primarily via these cells[11]. It is known that KCs play a 
key role in promoting hepatic steatosis, steatohepatitis 
and ballooning in NASH[44]; and generation of ROS in 
KCs rather than by HSCs has been associated with 
NAFLD disease progression[45]. Given the important 
role of KCs in NAFLD progression and their key role in 
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scavenging AGEs[46], we explored the effect of AGEs 
on primary KCs and showed that AGEs increase cell 
proliferation and the generation of ROS by these cells. 
As expected, in our HFHC model there was marked 
upregulation of a number of key proinflammatory and 
fibrogenic cytokines. It is unclear why, despite showing 
that AGEs increase oxidative stress, hepatocyte 
ballooning and fibrosis, we did not find they increased 
inflammatory infiltration of the liver or in inflammatory 
cytokines expression. In keeping with this finding, 
in a very similar dietary model of NASH, Lo et al[47] 
found that although diabetes worsened steatosis 
induced liver fibrosis this was not associated with 
measurable increases in liver inflammatory infiltration 
or proinflammatory cytokine levels. These finding 
suggest that profibrotic effects of AGEs and diabetes 
may not be mediated primarily through increasing 
hepatic inflammation. 
The formation of AGEs in foods involves the con-
densation of an amino group with the carbonyl group 
of a reducing carbohydrate (glucose, fructose, maltose, 
lactose or ribulose) to form intermediate Amadori 
products. Oxidation of Amadori products leads to a 
more stable compound, CML, used in studies as an 
indicator of the AGE content of foods[4]. A common 
method of high dietary AGE formation is via heating 
at high temperatures in non-aqueous environments 
(e.g., baking or broiling)[4]. High levels of AGEs are 
thus found in many common foods such as baked 
breads and biscuits/cookies, toasted breakfast cereals, 
grilled steak, brewed beer, and roasted coffee beans. 
For example, toasting white bread increases its 
AGE content by more than 3 times[48]. Interestingly, 
acidifying such foods prior to cooking by marinating 
them in acetic acid (vinegar) or lemon juice, reduces 
their CML content substantially without compromising 
palatability[49]. In this study, we have found reducing 
AGEs production by vinegar marination prior to 
baking can abrogate the harmful effects of a high AGE 
diet in an animal model of NAFLD. This may be one 
mechanism by which the Mediterranean diet which 
includes the use of vinegar and lemon juice marination 
is beneficial for metabolic health and in NAFLD[50]. 
It has been shown that patients with NASH have 
higher levels of circulating AGEs than those with 
simple steatosis[46]. However whether this reflects 
an increased dietary exposure to AGEs or greater 
endogenous AGE production in patients who have both 
fatty liver and glucose intolerance is unclear. Studies 
examining the relationship between dietary exposure 
to AGEs and the histological severity of liver injury in 
non-diabetic patients will help clarify this issue.
In conclusion, we show that high dietary AGE 
exposure worsens liver pathology in experimental 
NASH, implicating AGE/RAGE signalling in fatty liver 
disease progression. Decreasing dietary AGEs by 
altering food selection and cooking methods may thus 
offset the possible harmful effects afforded by a high 
AGE diet. If confirmed in human studies, our findings 
have broad implications for the way we process 
foods and the dietary advice given to patients with 
NAFLD. They also suggest a possible role for therapies 
targeting the AGE/RAGE pathway in the treatment and 
prevention of NASH.
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Figure 5  Effects of the high fructose, high cholesterol diet and dietary advanced glycation end products manipulation on fibrosis in the receptor for 
advanced glycation end products KO animals. A: The absence of receptor for advanced glycation end (RAGE) attenuated the effects of increasing the advanced 
glycation end products (AGEs) content of the high fructose, high cholesterol (HFHC) diet as evidenced by a reduction in picrosirius red staining to levels observed in 
animals on the HFHC diet alone; B: There was a commensurate reduction in COL1A gene expression; C: A reduction in hepatic 4-hydroxynonenal content (aP < 0.05).
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COMMENTS
Background
There is considerable interest in identifying the factors which drive progression 
of uncomplicated non-alcoholic fatty liver disease (NAFLD) to non-alcoholic 
steatohepatitis (NASH), cirrhosis and liver cancer. Advanced glycation end 
products (AGEs) are a complex group of compounds formed in foods that 
are highly processed or dry heated at high temperatures which have been 
implicated in the pathogenesis of diabetic complications. Our previous work in 
a methionine choline deficient model of NASH has shown that AGEs may be an 
important environmental risk factor that serves as a second hit driving simple 
steatosis to steatohepatitis and cirrhosis. The aims of the current study were 
to determine whether AGEs drive NAFLD progression in a long term high fat, 
high cholesterol, high fructose dietary model of NASH that mimics many of the 
features of human NASH. We also aimed to examine the role of the receptor for 
AGEs (RAGE) and Kupffer cells in this process. 
Research frontiers
There is major interest in identifying so-called second hits which drive liver 
inflammation and fibrosis in NAFLD. AGEs have been implicated in progression 
of a number of disease processes, including diabetic nephropathy, retinopathy, 
vasculopathy and neuropathy. This study investigates whether AGEs could 
represent an important potential dietary and pharmacological target in the 
management of the burgeoning problem of fatty liver disease.
Innovations and breakthroughs
This is the first study which examines the impact of altering dietary AGE content 
in a long term physiological model of NASH that utilises proportions of fats and 
fructose found typically in Western diets. We have found that changes in AGE 
content influence liver inflammation and fibrosis. This is also the first study to 
show that in RAGE knock out animals, these deleterious effects of AGEs are 
abrogated, suggesting a RAGE dependent pathway. Studies by Leung et al in 
isolated primary Kupffer cells also show AGEs increase cell proliferation and 
oxidative stress, suggesting a likely mechanism by which these compounds 
contribute to liver injury. 
Applications
Food sourcing and preparation methods that reduce AGE content could 
influence the progression of NAFLD. This study also suggests that pharma-
cological therapies which target the AGE/RAGE pathway may have a role in 
treatment of NAFLD.
Terminology
AGEs, also known as glycotoxins, are a complex group of compounds that are 
formed when active sugar moieties become bound to proteins causing browning 
and other irreversible modifications. Foods that are highly processed or dry 
heated at high temperatures, such as broiled foods, have particularly high AGE 
content. However, they are also formed endogenously and this occurs at an 
increased rate in diabetes, most likely because of hyperglycaemia. There is 
now considerable evidence that accumulation of AGEs are implicated in the 
pathogenesis of diabetic renal, neurological, retinal and vascular complications. 
AGEs act on several receptors but the receptor for advanced glycation end 
products (RAGE), a member of the immunoglobulin superfamily of cell-surface 
molecules, is the best characterised of these receptors. Engagement with 
RAGE, which in turn increases inflammation and oxidative stress, is thought to 
be the main way in which AGEs impart these pathogenic effects. This receptor 
is expressed in a number of cell types, including endothelial cells, vascular 
smooth muscle cells, peripheral blood mononuclear cells, macrophages 
(including Kupffer cells) and HSCs. 
Peer-review
A well designed and organized study. 
REFERENCES
1 Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras 
M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver 
disease and nonalcoholic steatohepatitis among a largely middle­
aged population utilizing ultrasound and liver biopsy: a prospective 
study. Gastroenterology 2011; 140: 124­131 [PMID: 20858492 
DOI: 10.1053/j.gastro.2010.09.038]
2 Arteel GE. Beyond reasonable doubt: who is the culprit in 
lipotoxicity in NAFLD/NASH? Hepatology 2012; 55: 2030­2032 
[PMID: 22422583 DOI: 10.1002/hep.25721]
3 Henle T. Protein­bound advanced glycation endproducts (AGEs) 
as bioactive amino acid derivatives in foods. Amino Acids 2005; 
29: 313­322 [PMID: 15997413 DOI: 10.1007/s00726­005­0200­2]
4 Goldberg T, Cai W, Peppa M, Dardaine V, Baliga BS, Uribarri J, 
Vlassara H. Advanced glycoxidation end products in commonly 
consumed foods. J Am Diet Assoc 2004; 104: 1287­1291 [PMID: 
15281050 DOI: 10.1016/j.jada.2004.05.214]
5 Aso Y, Inukai T, Tayama K, Takemura Y. Serum concentrations 
of advanced glycation endproducts are associated with the 
development of atherosclerosis as well as diabetic microangiopathy 
in patients with type 2 diabetes. Acta Diabetol 2000; 37: 87­92 
[PMID: 11194933]
6 Stitt AW, Bucala R, Vlassara H. Atherogenesis and advanced 
glycation: promotion, progression, and prevention. Ann N Y Acad 
Sci 1997; 811: 115­127; discussion 127­129 [PMID: 9186590]
7 Miyata T, Hori O, Zhang J, Yan SD, Ferran L, Iida Y, Schmidt 
AM. The receptor for advanced glycation end products (RAGE) is 
a central mediator of the interaction of AGE­beta2microglobulin 
with human mononuclear phagocytes via an oxidant­sensitive 
pathway. Implications for the pathogenesis of dialysis­related 
amyloidosis. J Clin Invest 1996; 98: 1088­1094 [PMID: 8787669 
DOI: 10.1172/JCI118889]
8 Brett J, Schmidt AM, Yan SD, Zou YS, Weidman E, Pinsky 
D, Nowygrod R, Neeper M, Przysiecki C, Shaw A. Survey of 
the distribution of a newly characterized receptor for advanced 
glycation end products in tissues. Am J Pathol 1993; 143: 
1699­1712 [PMID: 8256857]
9 Patel R, Baker SS, Liu W, Desai S, Alkhouri R, Kozielski R, 
Mastrandrea L, Sarfraz A, Cai W, Vlassara H, Patel MS, Baker 
RD, Zhu L. Effect of dietary advanced glycation end products on 
mouse liver. PLoS One 2012; 7: e35143 [PMID: 22496902 DOI: 
10.1371/journal.pone.0035143]
10 Ekong U, Zeng S, Dun H, Feirt N, Guo J, Ippagunta N, Guarrera 
JV, Lu Y, Weinberg A, Qu W, Ramasamy R, Schmidt AM, Emond 
JC. Blockade of the receptor for advanced glycation end products 
attenuates acetaminophen­induced hepatotoxicity in mice. J 
Gastroenterol Hepatol 2006; 21: 682­688 [PMID: 16677153]
11 Zeng S, Feirt N, Goldstein M, Guarrera J, Ippagunta N, Ekong 
U, Dun H, Lu Y, Qu W, Schmidt AM, Emond JC. Blockade of 
receptor for advanced glycation end product (RAGE) attenuates 
ischemia and reperfusion injury to the liver in mice. Hepatology 
2004; 39: 422­432 [PMID: 14767995 DOI: 10.1002/hep.20045]
12 Goodwin M, Herath C, Jia Z, Leung C, Coughlan MT, Forbes J, 
Angus P. Advanced glycation end products augment experimental 
hepatic fibrosis. J Gastroenterol Hepatol 2013; 28: 369­376 [PMID: 
23173780]
13 Lohwasser C, Neureiter D, Popov Y, Bauer M, Schuppan D. Role 
of the receptor for advanced glycation end products in hepatic 
fibrosis. World J Gastroenterol 2009; 15: 5789­5798 [PMID: 
19998499 DOI: 10.3748/wjg.15.5789]
14 Hyogo H, Yamagishi S, Iwamoto K, Arihiro K, Takeuchi M, Sato T, 
Ochi H, Nonaka M, Nabeshima Y, Inoue M, Ishitobi T, Chayama 
K, Tazuma S. Elevated levels of serum advanced glycation 
end products in patients with non­alcoholic steatohepatitis. J 
Gastroenterol Hepatol 2007; 22: 1112­1119 [PMID: 17559366 
DOI: 10.1111/j.1440­1746.2007.04943.x]
15 Basta G, Schmidt AM, De Caterina R. Advanced glycation end 
products and vascular inflammation: implications for accelerated 
atherosclerosis in diabetes. Cardiovasc Res 2004; 63: 582­592 
[PMID: 15306213 DOI: 10.1016/j.cardiores.2004.05.001]
16 Santos JC, Valentim IB, de Araújo OR, Ataide Tda R, Goulart 
MO. Development of nonalcoholic hepatopathy: contributions of 
oxidative stress and advanced glycation end products. Int J Mol 
8038 September 21, 2016|Volume 22|Issue 35|WJG|www.wjgnet.com
 COMMENTS
Leung C et al . Progression of NAFLD
Sci 2013; 14: 19846­19866 [PMID: 24084729 DOI: 10.3390/
ijms141019846]
17 Adams LA, Sanderson S, Lindor KD, Angulo P. The histological 
course of nonalcoholic fatty liver disease: a longitudinal study of 
103 patients with sequential liver biopsies. J Hepatol 2005; 42: 
132­138 [PMID: 15629518 DOI: 10.1016/j.jhep.2004.09.012]
18 Ratziu V, Munteanu M, Charlotte F, Bonyhay L, Poynard T. 
Fibrogenic impact of high serum glucose in chronic hepatitis C. J 
Hepatol 2003; 39: 1049­1055 [PMID: 14642625 DOI: 10.1016/
S0168­8278(03)00456­2]
19 Leung C, Herath CB, Jia Z, Goodwin M, Mak KY, Watt MJ, 
Forbes JM, Angus PW. Dietary glycotoxins exacerbate progression 
of experimental fatty liver disease. J Hepatol 2014; 60: 832­838 
[PMID: 24316518 DOI: 10.1016/j.jhep.2013.11.033]
20 Larter CZ , Yeh MM. Animal models of NASH: getting 
both pathology and metabolic context right. J Gastroenterol 
Hepatol 2008; 23: 1635­1648 [PMID: 18752564 DOI: 10.1111/
j.1440­1746.2008.05543.x]
21 Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, 
Tang PH, Miles L, Miles MV, Balistreri WF, Woods SC, Seeley RJ. 
High­fructose, medium chain trans fat diet induces liver fibrosis 
and elevates plasma coenzyme Q9 in a novel murine model of 
obesity and nonalcoholic steatohepatitis. Hepatology 2010; 52: 
934­944 [PMID: 20607689 DOI: 10.1002/hep.23797]
22 Van Rooyen DM, Gan LT, Yeh MM, Haigh WG, Larter CZ, 
Ioannou G, Teoh NC, Farrell GC. Pharmacological cholesterol 
lowering reverses fibrotic NASH in obese, diabetic mice with 
metabolic syndrome. J Hepatol 2013; 59: 144­152 [PMID: 
23500152 DOI: 10.1016/j.jhep.2013.02.024]
23 Xu ZJ, Fan JG, Ding XD, Qiao L, Wang GL. Characterization of 
high­fat, diet­induced, non­alcoholic steatohepatitis with fibrosis 
in rats. Dig Dis Sci 2010; 55: 931­940 [PMID: 19459046 DOI: 
10.1007/s10620­009­0815­3]
24 Takagi Y, Kashiwagi A, Tanaka Y, Asahina T, Kikkawa R, Shigeta 
Y. Significance of fructose­induced protein oxidation and formation 
of advanced glycation end product. J Diabetes Complications 
1995; 9: 87­91 [PMID: 7599353 DOI: 10.1016/1056­8727(94)000
22­G]
25 David E. A Book of Mediterranean Food (New York Review 
Books Classics). New York City: New York Review Books, 2002
26 Andrikopoulos S, Blair AR, Deluca N, Fam BC, Proietto J. 
Evaluating the glucose tolerance test in mice. Am J Physiol 
Endocrinol Metab 2008; 295: E1323­E1332 [PMID: 18812462 
DOI: 10.1152/ajpendo.90617.2008]
27 Nobécourt E, Tabet F, Lambert G, Puranik R, Bao S, Yan L, 
Davies MJ, Brown BE, Jenkins AJ, Dusting GJ, Bonnet DJ, 
Curtiss LK, Barter PJ, Rye KA. Nonenzymatic glycation impairs 
the antiinflammatory properties of apolipoprotein A­I. Arterioscler 
Thromb Vasc Biol 2010; 30: 766­772 [PMID: 20110571 DOI: 
10.1161/ATVBAHA.109.201715]
28 Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, 
Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp­Arida 
A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of 
a histological scoring system for nonalcoholic fatty liver disease. 
Hepatology 2005; 41: 1313­1321 [PMID: 15915461 DOI: 10.1002/
hep.20701]
29 Herath CB, Warner FJ, Lubel JS, Dean RG, Jia Z, Lew RA, Smith 
AI, Burrell LM, Angus PW. Upregulation of hepatic angiotensin­
converting enzyme 2 (ACE2) and angiotensin­(1­7) levels in 
experimental biliary fibrosis. J Hepatol 2007; 47: 387­395 [PMID: 
17532087 DOI: 10.1016/j.jhep.2007.03.008]]
30 Patella S, Phillips DJ, Tchongue J, de Kretser DM, Sievert W. 
Follistatin attenuates early liver fibrosis: effects on hepatic stellate 
cell activation and hepatocyte apoptosis. Am J Physiol Gastrointest 
Liver Physiol 2006; 290: G137­G144 [PMID: 16123203 DOI: 
10.1152/ajpgi.00080.2005]
31 Kitani H, Takenouchi T, Sato M, Yoshioka M, Yamanaka N. A 
simple and efficient method to isolate macrophages from mixed 
primary cultures of adult liver cells. J Vis Exp 2011; (51): pii 2757 
[PMID: 21654622]
32 Guimarães EL, Empsen C, Geerts A, van Grunsven LA. Advanced 
glycation end products induce production of reactive oxygen 
species via the activation of NADPH oxidase in murine hepatic 
stellate cells. J Hepatol 2010; 52: 389­397 [PMID: 20133001 DOI: 
10.1016/j.jhep.2009.12.007]
33 Stirban A, Tschoepe D. Comment on “Advanced glycation 
endproducts in food and their effects on health” by Poulsen et al. 
(2013) Food and Chemical Toxicology 60, 10­37. Food Chem 
Toxicol 2014; 64: 411 [PMID: 24316312]
34 Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander­Tetri 
BA. Nonalcoholic fatty liver disease (NAFLD) activity score and 
the histopathologic diagnosis in NAFLD: distinct clinicopathologic 
meanings. Hepatology 2011; 53: 810­820 [PMID: 21319198 DOI: 
10.1002/hep.24127]
35 Goh SY, Cooper ME. Clinical review: The role of advanced 
glycation end products in progression and complications of 
diabetes. J Clin Endocrinol Metab 2008; 93: 1143­1152 [PMID: 
18182449 DOI: 10.1210/jc.2007­1817]
36 Liu Y, Meyer C, Xu C, Weng H, Hellerbrand C, ten Dijke P, 
Dooley S. Animal models of chronic liver diseases. Am J Physiol 
Gastrointest Liver Physiol 2013; 304: G449­G468 [PMID: 
23275613 DOI: 10.1152/ajpgi.00199.2012]
37 Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic 
fatty liver disease: the multiple parallel hits hypothesis. Hepatology 
2010; 52: 1836­1846 [PMID: 21038418 DOI: 10.1002/hep.24001]
38 Huang JS, Guh JY, Chen HC, Hung WC, Lai YH, Chuang LY. 
Role of receptor for advanced glycation end­product (RAGE) 
and the JAK/STAT­signaling pathway in AGE­induced collagen 
production in NRK­49F cells. J Cell Biochem 2001; 81: 102­113 
[PMID: 11180401 DOI: 10.1002/1097­4644(20010401)81]
39 Iwamoto K, Kanno K, Hyogo H, Yamagishi S, Takeuchi M, 
Tazuma S, Chayama K. Advanced glycation end products 
enhance the proliferation and activation of hepatic stellate cells. J 
Gastroenterol 2008; 43: 298­304 [PMID: 18458846 DOI: 10.1007/
s00535­007­2152­7]
40 Zhan SS, Jiang JX, Wu J, Halsted C, Friedman SL, Zern MA, 
Torok NJ. Phagocytosis of apoptotic bodies by hepatic stellate 
cells induces NADPH oxidase and is associated with liver fibrosis 
in vivo. Hepatology 2006; 43: 435­443 [PMID: 16496318 DOI: 
10.1002/hep.21093]
41 Matsuzawa N, Takamura T, Kurita S, Misu H, Ota T, Ando H, 
Yokoyama M, Honda M, Zen Y, Nakanuma Y, Miyamoto K, 
Kaneko S. Lipid­induced oxidative stress causes steatohepatitis 
in mice fed an atherogenic diet. Hepatology 2007; 46: 1392­1403 
[PMID: 17929294 DOI: 10.1002/hep.21874]
42 Poli G, Biasi F, Leonarduzzi G. 4­Hydroxynonenal­protein 
adducts: A reliable biomarker of lipid oxidation in liver diseases. 
Mol Aspects Med 2008; 29: 67­71 [PMID: 18158180 DOI: 
10.1016/j.mam.2007.09.016]
43 Smedsrød B, Melkko J, Araki N, Sano H, Horiuchi S. Advanced 
glycation end products are eliminated by scavenger­receptor­
mediated endocytosis in hepatic sinusoidal Kupffer and endothelial 
cells. Biochem J 1997; 322 (Pt 2): 567­573 [PMID: 9065778]
44 Stienstra R, Saudale F, Duval C, Keshtkar S, Groener JE, van 
Rooijen N, Staels B, Kersten S, Müller M. Kupffer cells promote 
hepatic steatosis via interleukin­1beta­dependent suppression 
of peroxisome proliferator­activated receptor alpha activity. 
Hepatology 2010; 51: 511­522 [PMID: 20054868 DOI: 10.1002/
hep.23337]
45 Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap 
FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM. 
Inhibition of NADPH oxidase prevents advanced glycation end 
product­mediated damage in diabetic nephropathy through a 
protein kinase C­alpha­dependent pathway. Diabetes 2008; 57: 
460­469 [PMID: 17959934 DOI: 10.2337/db07­1119]
46 Hyogo H, Yamagishi S. Advanced glycation end products (AGEs) 
and their involvement in liver disease. Curr Pharm Des 2008; 14: 
969­972 [PMID: 18473847]
47 Lo L, McLennan SV, Williams PF, Bonner J, Chowdhury S, 
McCaughan GW, Gorrell MD, Yue DK, Twigg SM. Diabetes is 
8039 September 21, 2016|Volume 22|Issue 35|WJG|www.wjgnet.com
Leung C et al . Progression of NAFLD
a progression factor for hepatic fibrosis in a high fat fed mouse 
obesity model of non­alcoholic steatohepatitis. J Hepatol 2011; 55: 
435­444 [PMID: 21184785 DOI: 10.1016/j.jhep.2010.10.039]
48 Vlassara H, Striker G. Glycotoxins in the diet promote diabetes 
and diabetic complications. Curr Diab Rep 2007; 7: 235­241 
[PMID: 17547841 DOI: 10.1007/s11892­007­0037­z]
49 Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, 
Yong A, Striker GE, Vlassara H. Advanced glycation end products 
in foods and a practical guide to their reduction in the diet. J 
Am Diet Assoc 2010; 110: 911­16.e12 [PMID: 20497781 DOI: 
10.1016/j.jada.2010.03.018]
50 Hoffman R, Gerber M. Evaluating and adapting the Mediterranean 
diet for non­Mediterranean populations: a critical appraisal. Nutr 
Rev 2013; 71: 573­584 [PMID: 24032362 DOI: 10.1111/nure.12040]
P- Reviewer: Busuttil RW, Mendez­Sanchez N, Tanoglu A 
S- Editor: Qi Y    L- Editor: A    E- Editor: Ma S
8040 September 21, 2016|Volume 22|Issue 35|WJG|www.wjgnet.com
Leung C et al . Progression of NAFLD
                                      © 2016 Baishideng Publishing Group Inc. All rights reserved.
Published by Baishideng Publishing Group Inc
8226 Regency Drive, Pleasanton, CA 94588, USA
Telephone: +1-925-223-8242
Fax: +1-925-223-8243
E-mail: bpgoffice@wjgnet.com
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
http://www.wjgnet.com
I S S N  1 0  0 7  -   9  3 2  7
9    7 7 1 0  07   9 3 2 0 45
3 5
